Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer
Xueping Qu(Unknown), Carlos Bais(Eos Neuroscience (United States))
Cited by 16
Related Papers
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
|Proceedings of the National Academy of Sciences|2010|666
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
|Nature|2021|603